Lovenox - 0075-0626-03 - (enoxaparin sodium)

Alphabetical Index


Drug Information of Lovenox

Product NDC: 0075-0626
Proprietary Name: Lovenox
Non Proprietary Name: enoxaparin sodium
Active Ingredient(s): 300    mg/3mL & nbsp;   enoxaparin sodium
Administration Route(s): INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of Lovenox

Product NDC: 0075-0626
Labeler Name: sanofi-aventis U.S. LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020164
Marketing Category: NDA
Start Marketing Date: 19930329

Package Information of Lovenox

Package NDC: 0075-0626-03
Package Description: 1 VIAL, MULTI-DOSE in 1 CARTON (0075-0626-03) > 3 mL in 1 VIAL, MULTI-DOSE

NDC Information of Lovenox

NDC Code 0075-0626-03
Proprietary Name Lovenox
Package Description 1 VIAL, MULTI-DOSE in 1 CARTON (0075-0626-03) > 3 mL in 1 VIAL, MULTI-DOSE
Product NDC 0075-0626
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name enoxaparin sodium
Dosage Form Name INJECTION
Route Name INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 19930329
Marketing Category Name NDA
Labeler Name sanofi-aventis U.S. LLC
Substance Name ENOXAPARIN SODIUM
Strength Number 300
Strength Unit mg/3mL
Pharmaceutical Classes Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC]

Complete Information of Lovenox


General Information